Treatment of Uncomplicated Type B Aortic Dissection: Optimal Medical Therapy vs TEVAR + Optimal Medical Therapy.

IF 0.7 4区医学 Q4 PERIPHERAL VASCULAR DISEASE

Vascular and Endovascular Surgery Pub Date : 2024-01-01 Epub Date: 2023-06-26 DOI:10.1177/15385744231184671

Michael Nooromid, Brandon A Creisher, Babak Abai

引用次数: 0

Abstract

Optimal Medical Therapy (OMT) has been the accepted mode of treatment for uncomplicated Type B Aortic Dissection (uTBAD). There is growing evidence that despite the short-term benefits of OMT, patients suffer deleterious consequences in the long-term with OMT alone. Thoracic Endovascular Aortic Repair (TEVAR) along with OMT has emerged as an alternative option for patients with uTBAD. This study evaluates the available literature for TEVAR + OMT as an alternative to OMT for treatment of uTBAD. In addition, issues related to TEVAR as a treatment for uTBAD are discussed.

查看原文本刊更多论文

无并发症B型主动脉夹层的治疗:最佳药物治疗vs TEVAR +最佳药物治疗。

最佳药物治疗(OMT)已成为治疗无并发症B型主动脉夹层(uTBAD)的公认模式。越来越多的证据表明，尽管OMT有短期的好处，但长期来看，患者单独使用OMT会遭受有害的后果。胸血管内主动脉修复术(TEVAR)和OMT已成为uTBAD患者的另一种选择。本研究评估了TEVAR + OMT作为替代OMT治疗uTBAD的现有文献。此外，还讨论了TEVAR作为uTBAD治疗方法的相关问题。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Vascular and Endovascular Surgery SURGERY-PERIPHERAL VASCULAR DISEASE

CiteScore

1.70

自引率

11.10%

发文量

132

审稿时长

4-8 weeks

期刊介绍： Vascular and Endovascular Surgery (VES) is a peer-reviewed journal that publishes information to guide vascular specialists in endovascular, surgical, and medical treatment of vascular disease. VES contains original scientific articles on vascular intervention, including new endovascular therapies for peripheral artery, aneurysm, carotid, and venous conditions. This journal is a member of the Committee on Publication Ethics (COPE).